La cadena de opciones muestra datos clave de las opciones de acciones de Opthea a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Opthea..

Opthea (NASDAQ:OPT) Bolsa, Cadena de Opciones

OPTHEA LTD-SPON ADR

Opthea

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.

Opthea Limited - American Depositary Shares

Opthea Ltd

Opus - United States Dollar

ORIENTAL PET & MINERAL B by Oriental Petroleum & Mineral

OPTIMUS GROUP CO LTD. by OPTIMUS GROUP CO LTD.

Optimus Group Co Ltd

OPTIMI HEALTH CORP by OPTIMI HEALTH CORP.

Optimi Health Corp

OPTEC INTERNATIONAL INC by Optec International, Inc.

Optec International Inc

OPTIMUM INTRACTVE USA NEW by Optimum Interactive USA Ltd.

Optimum Interactive USA Ltd

OptiNose Inc COM NEW

Ocean Power Technologies, Inc. Common Stock

Ocean Power Technologies Inc

Syntec Optics Holdings, Inc. - Class A Common Stock

Syntec Optics Holdings Inc

Optimize Strategy Index ETF

Health Care

Press Releases

Opthea Announces Publication in Diabetic Macular Edema

News

Opthea to Host Investor Days in New York and Australia

Opthea Wet AMD Data Featured at Macula Society Meeting

Opthea to Present at Oppenheimer Healthcare Conference

Opthea Completes COAST Final Week 52 Patient Visit

Opthea Completes Drug Product PPQ Campaign

Earnings

Opthea Reports Half Year Results and Business Updates

Analyst Ratings

General

Opthea Announces Phase 2b Wet AMD Publication

Opthea Announces COAST Phase 3 Trial Topline Results

Opthea Announces Decision to Discontinue Wet AMD Trials

AbbVie

Alnylam Pharmaceuticals, Inc. - Common Stock

Alnylam Pharmaceuticals

Amgen

argenx

Ascendis Pharma A/S - American Depositary Shares

Ascendis Pharma

BridgeBio Pharma

Biogen

BioMarin Pharmaceutical Inc. - Common Stock

BioMarin Pharmaceutical

BioNTech

Caris Life Sciences

Exact Sciences Corporation - Common Stock

Exact Sciences

Exelixis

Gilead Sciences

Genmab

Incyte

Insmed

Madrigal Pharmaceuticals, Inc. - Common Stock

Madrigal Pharmaceuticals

Moderna

Neurocrine Biosciences, Inc. - Common Stock

Neurocrine Biosciences

Natera

BeOne Medicines Ltd. - American Depositary Shares

BeOne Medicines

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals

Roivant Sciences

Summit Therapeutics

United Therapeutics Corporation - Common Stock

United Therapeutics

Vertex Pharmaceuticals Incorporated - Common Stock

Comments

Opthea

Opthea (OPT) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL